Latest Expert Opinions

Signal
Opinion
Expert
PARTIAL BUY
PARTIAL BUY
September 13, 2018

Two years ago, Alaris had two problem investments. Pays an 8% dividend. AD is turning things around with a few more investments, and they have reset their royalty rates. Things are definitely looking better. A 98% payout ratio, but that will be threatened if there's another problem investment. Cheap now. Give it one more quarter to see if things continue to do well, but you can pick away at it now.

Alaris Royalty (AD-T)
September 13, 2018

Two years ago, Alaris had two problem investments. Pays an 8% dividend. AD is turning things around with a few more investments, and they have reset their royalty rates. Things are definitely looking better. A 98% payout ratio, but that will be threatened if there's another problem investment. Cheap now. Give it one more quarter to see if things continue to do well, but you can pick away at it now.

Ryan Modesto
Managing Partner, 5i Research
Price
$19.450
Owned
Unknown
COMMENT
COMMENT
September 13, 2018

A high-risk company in an interesting space. Healthcare providers and governments want to keep people out of hospitals, so Reliq benefits. Reliq's technology can monitor people recovering from home. They're signing contracts in Texas. They target $26 million annual recurring revenue. They've had a few product missteps, so they need to deliver that $26 million target. They're also in the process of signing contracts in Canada and Australia. This could be a big business one day, but there's a lot of risk here.

A high-risk company in an interesting space. Healthcare providers and governments want to keep people out of hospitals, so Reliq benefits. Reliq's technology can monitor people recovering from home. They're signing contracts in Texas. They target $26 million annual recurring revenue. They've had a few product missteps, so they need to deliver that $26 million target. They're also in the process of signing contracts in Canada and Australia. This could be a big business one day, but there's a lot of risk here.

Ryan Modesto
Managing Partner, 5i Research
Price
$1.210
Owned
Unknown
BUY
BUY
September 13, 2018

They've done very well with a new CEO following a legal fight with a subsidiary a few years ago. A good growth play on semiconductors. Has a good balance sheet and growth potential by branching into other semicondutor components. Keep a 3-year time frame on this and expect some volatility.

Photon Control (PHO-T)
September 13, 2018

They've done very well with a new CEO following a legal fight with a subsidiary a few years ago. A good growth play on semiconductors. Has a good balance sheet and growth potential by branching into other semicondutor components. Keep a 3-year time frame on this and expect some volatility.

Ryan Modesto
Managing Partner, 5i Research
Price
$2.300
Owned
Yes
DON'T BUY
DON'T BUY
September 13, 2018

Shares have done well. They depend long-term contracts wth Air Canada, and these contracts support their heavy debt. But what happens if things go wrong with Air Canada, given all this debt? He's on the sidelines here.

Chorus Aviation Inc (CHR-T)
September 13, 2018

Shares have done well. They depend long-term contracts wth Air Canada, and these contracts support their heavy debt. But what happens if things go wrong with Air Canada, given all this debt? He's on the sidelines here.

Ryan Modesto
Managing Partner, 5i Research
Price
$7.620
Owned
No
WAIT
WAIT
September 13, 2018

Slashed their sales growth forecast today. He likes it, but high-valuation companies like this get hit if they slip in a report. They have a long runways in organic growth just through price increases over time. It could drift a bit lower, so wait a bit, but it's fine to have long term. A shareholder-friendly company that regularly buys back shares.

Dollarama Inc. (DOL-T)
September 13, 2018

Slashed their sales growth forecast today. He likes it, but high-valuation companies like this get hit if they slip in a report. They have a long runways in organic growth just through price increases over time. It could drift a bit lower, so wait a bit, but it's fine to have long term. A shareholder-friendly company that regularly buys back shares.

Ryan Modesto
Managing Partner, 5i Research
Price
$43.120
Owned
Unknown
BUY WEAKNESS
BUY WEAKNESS
September 13, 2018

Likes it and has owned it for a long time. They do beef jerky and other specialty foods. They buy smaller companies. Strong management. It will drift from time to time, like now. High valuation name. Be patient with this. Growth by
acquisition. They buyback shares and increase dividends. Good to own. Buy on this pullback.

Likes it and has owned it for a long time. They do beef jerky and other specialty foods. They buy smaller companies. Strong management. It will drift from time to time, like now. High valuation name. Be patient with this. Growth by
acquisition. They buyback shares and increase dividends. Good to own. Buy on this pullback.

Ryan Modesto
Managing Partner, 5i Research
Price
$99.860
Owned
Yes
BUY
BUY
September 13, 2018

It has done well. Likes it. It buys smaller companies. They deal with customs and borders for customers who don't want to deal with that hassle. It has a steady growth rate in recurring revenues.

Descartes (DSG-T)
September 13, 2018

It has done well. Likes it. It buys smaller companies. They deal with customs and borders for customers who don't want to deal with that hassle. It has a steady growth rate in recurring revenues.

Ryan Modesto
Managing Partner, 5i Research
Price
$44.440
Owned
Unknown